• 120 Citations
  • 6 h-Index
19972018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Micaela Petrone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Gestational Trophoblastic Disease Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Folate Receptor 1 Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Folic Acid Medicine & Life Sciences
Cesarean Section Medicine & Life Sciences
Fertility Medicine & Life Sciences
Hydatidiform Mole Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

  • 120 Citations
  • 6 h-Index
  • 15 Article
  • 3 Review article

Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues

Bergamini, A., Petrone, M., Rabaiotti, E., Pella, F., Cioffi, R., Rossi, EG., Di Mattei, V., Candiani, M. & Mangili, G., 2018, In : Gynecological Endocrinology. 34, 4, p. 305-308 4 p.

Research output: Contribution to journalArticle

Italy
Fertility
Fertility Preservation
Patient Selection
Assisted Reproductive Techniques

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Farolfi, A., Petrone, M., Scarpi, E., Gallà, V., Greco, F., Casanova, C., Longo, L., Cormio, G., Orditura, M., Bologna, A., Zavallone, L., Ventriglia, J., Franzese, E., Loizzi, V., Giardina, D., Pigozzi, E., Cioffi, R., Pignata, S., Giorda, G. & de Giorgi, U., 2018, In : Targeted Oncology. 13, 4, p. 469-479 11 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Drug Therapy
Disease-Free Survival
Lymphocytes
Survival

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Farolfi, A., Petrone, M., Scarpi, E., Gallà, V., Greco, F., Casanova, C., Longo, L., Cormio, G., Orditura, M., Bologna, A., Zavallone, L., Ventriglia, J., Franzese, E., Loizzi, V., Giardina, D., Pigozzi, E., Cioffi, R., Pignata, S., Giorda, G. & De Giorgi, U., Aug 2018, In : Targeted Oncology. 13, 4, p. 469-479 11 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Disease-Free Survival
Drug Therapy
Lymphocytes
Survival
4 Citations (Scopus)

Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group

Cioffi, R., Bergamini, A., Gadducci, A., Cormio, G., Giorgione, V., Petrone, M., Rabaiotti, E., Pella, F., Candiani, M. & Mangili, G., Feb 1 2018, In : International Journal of Gynecological Cancer. 28, 2, p. 332-337 6 p.

Research output: Contribution to journalArticle

Gestational Trophoblastic Disease
Drug Therapy
Hysterectomy
Pregnancy
Gynecology

Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group

Cioffi, R., Bergamini, A., Gadducci, A., Cormio, G., Giorgione, V., Petrone, M., Rabaiotti, E., Pella, F., Candiani, M. & Mangili, G., 2018, In : International Journal of Gynecological Cancer. 28, 2, p. 332-337 6 p.

Research output: Contribution to journalArticle

Gestational Trophoblastic Disease
Drug Therapy
Hysterectomy
Pregnancy
Gynecology